HIRSCHMAN ORIN 13D/13G Filings for X4 Pharmaceuticals, Inc. (XFOR)

HIRSCHMAN ORIN 13D and 13G filings for X4 Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2022-02-11
3:17 pm
Purchase		2021-12-3113GX4 Pharmaceuticals, Inc.
XFOR		HIRSCHMAN ORIN1,531,600
6.200%		72,700increase
(+4.98%)		Filing
2021-06-28
7:32 pm
Purchase		2021-06-1613GX4 Pharmaceuticals, Inc.
XFOR		HIRSCHMAN ORIN1,458,900
6.200%		1,458,900increase
(New Position)		Filing